NCT02927158 Exome and Genome Analysis to Elucidate Genetic Etiologies and Population Characteristics in the Plain Community
| NCT ID | NCT02927158 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pittsburgh |
| Condition | Undiagnosed Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2016-08 |
| Primary Completion | 2036-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2016-08 with a primary completion date of 2036-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is designed to utilize whole exome and whole genome sequencing techniques to identify underlying genetic causes for undiagnosed disorders in the Plain Communities, and to do population genetic studies looking at genetic drift and founder mutations in this unique population.
Eligibility Criteria
Inclusion Criteria: * Any person of Amish or Mennonite descent Exclusion Criteria: * Individuals who are not of Amish or Mennonite descent
Contact & Investigator
Lina Ghaloul Gonzalez, MD
PRINCIPAL INVESTIGATOR
University of Pittsburgh
Frequently Asked Questions
Who can join the NCT02927158 clinical trial?
This trial is open to participants of all sexes, up to 100 Years, studying Undiagnosed Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02927158 currently recruiting?
Yes, NCT02927158 is actively recruiting participants. Contact the research team at catherine.walshvockley@chp.edu for enrollment information.
Where is the NCT02927158 trial being conducted?
This trial is being conducted at Pittsburgh, United States.
Who is sponsoring the NCT02927158 clinical trial?
NCT02927158 is sponsored by University of Pittsburgh. The principal investigator is Lina Ghaloul Gonzalez, MD at University of Pittsburgh. The trial plans to enroll 300 participants.